Advertisement

Topics

Axonics Modulation Technologies, Inc. Company Profile

21:58 EDT 21st June 2018 | BioPortfolio

Axonics, based in Irvine, Calif., is a privately held venture-backed pre-revenue company developing novel implantable neuromodulation technology licensed from The Alfred Mann Foundation directed toward a number of clinical indications, including the treatment of chronic pain and overactive bladder.


News Articles [252 Associated News Articles listed on BioPortfolio]

Funding round, credit facility bring in $40.1M for Axonics Modulation

An equity financing round brought in $20.1 million for Irvine, Calif.-based Axonics Modulation Technologies, which manufactur -More- 

Axonics brings in $40.1mm with concurrent equity and debt financings

Axonics Modulation Technologies Inc. (neuromodulation device for urologic disorders) raised a total of $40.1mm through concurrent equity and debt financings. The $20.1mm undisclosed late-stage equity ...

First Patients Implanted with Axonics® Sacral Neuromodulation System in U.S. FDA Pivotal Study

Axonics Modulation Technologies, Inc., developer of the first rechargeable sacral neuromodulation (r-SNM™) system for the treatment of urinary and bowel dysfunction, today annou...

Axonics® Announces Publication of Clinical Articles about Its Sacral Neuromodulation System in ...

Company ContactAxonics Modulation Technologies, Inc.Dan Dearen, +1-949-396-6320Chief Operating & Financial Officerddearen@axonicsmodulation.comorInvestor & Media ContactW2OpureMa...

Axonics® Announces Publication of Clinical Articles about Its Sacral Neuromodulation System in the Journal of Neurourology and Urodynamics

Axonics Modulation Technologies, Inc. announced today that three clinical articles relating to its miniaturized, rechargeable Sacral Neuromodulation system (Axonics r-SNM™ Syste...

Axonics® Sacral Neuromodulation System Receives Marketing Approval in Australia

Axonics Modulation Technologies, Inc. announced today that it received marketing approval from the Australian Department of Health, Therapeutic Goods Administration (TGA) for the ...

Axonics® Announces $40 Million Financing

Equity Round of $20 million led by Longitude Capital with Silicon Valley Bank Providing a $20 million Credit Facility Axonics Modulation Technologies, Inc., a privately-held d...

Horizon Discovery enters agreement with immuno-oncology company

Horizon Discovery Group, specialists in gene editing and gene modulation technologies, has entered into a non-exclusive out-licensing agreement with a US-based immuno-oncology therapeutics developer f...

PubMed Articles [729 Associated PubMed Articles listed on BioPortfolio]

Conditional Degrons for Controlling Protein Expression at the Protein Level.

The conditional depletion of a protein of interest (POI) is useful not only for loss-of-function studies, but also for the modulation of biological pathways. Technologies that work at the level of DNA...

Three month clinical results with a rechargeable sacral neuromodulation system for the treatment of overactive bladder.

The primary aim of the RELAX-OAB study is to confirm the safety and efficacy of the Axonics r-SNM System, a miniaturized, rechargeable SNM system.

Chemogenetic Tools for Causal Cellular and Neuronal Biology.

Chemogenetic technologies enable selective pharmacological control of specific cell populations. An increasing number of approaches have been developed that modulate different signaling pathways. Sele...

Catastrophizing Interferes with Cognitive Modulation of Pain in Women with Fibromyalgia.

Pain modulation is a critical function of the nociceptive system that includes the ability to engage descending pain control systems to maintain a functional balance between facilitation and inhibitio...

Two-level and two-period modulation for closed-loop interferometric fiber optic gyroscopes.

We propose and experimentally demonstrate a modulation technique for closed-loop interferometric fiber optic gyroscopes that improves its scale factor control and allows for the construction of gyrosc...

Clinical Trials [826 Associated Clinical Trials listed on BioPortfolio]

Magnetic Field Modulation Pillow for Insomnia Clinical Trial

This observational study was designed to explore the clinical effect of magnetic field modulation system on insomnia patients and provide a new solution for insomnia treatment.

Study of PM Modulation Therapy in Trial Phase

This is a prospective, open label, observational trialing of PM modulation therapy in patients with chronic intractable low back pain

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

The PulmoTrack® 2010 with WIM-PC™ Technologies device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order t...

Long Term Efficacy of Sacral Nerve Modulation (SNM) in Patients With Constipation or Stool Incontinence

The aim of this study is to determine the success rate, the success duration, the complication rate, maintenance effort and quality of life several years after sacral nerve modulation (SNM...

Companies [1309 Associated Companies listed on BioPortfolio]

Axonics Modulation Technologies, Inc.

Axonics, based in Irvine, Calif., is a privately held venture-backed pre-revenue company developing novel implantable neuromodulation technology licensed from The Alfred Mann Foun...

Spinal Modulation, Inc.

Spinal Modulation, headquartered in Menlo Park, California, is an early stage, private medical device company developing the next generation neuromodulation system for treating ch...

MultiCell Technologies

MultiCell Technologies, Inc. is an integrated biopharmaceutical company committed to the development of breakthrough therapeutics based on a portfolio of therapeutic candidates and patented drug devel...

TNI BioTech, Inc.

TNI BioTech, Inc. is a biotech company working to combat chronic, life-threatening diseases through the activation and modulation of the body's immune system using our patented im...

TapImmune Inc.

TapImmune Inc. is an immunotherapy company specializing in the development of innovative vaccine technologies for the treatment of cancer and infectious disease. The Company’...

More Information about "Axonics Modulation Technologies, Inc." on BioPortfolio

We have published hundreds of Axonics Modulation Technologies, Inc. news stories on BioPortfolio along with dozens of Axonics Modulation Technologies, Inc. Clinical Trials and PubMed Articles about Axonics Modulation Technologies, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Axonics Modulation Technologies, Inc. Companies in our database. You can also find out about relevant Axonics Modulation Technologies, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Pain
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...


Corporate Database Quicklinks



Searches Linking to this Company Record